Table 2.
Characteristic | Total N = 730 |
Surgical procedure of keratoplasty | p-value1 | |||
---|---|---|---|---|---|---|
[A] PK N = 198 |
[B] DSAEK N = 277 |
[C] nDSAEK N = 138 |
[D] DMEK N = 117 |
|||
Indication, n (%) | ||||||
[01] Failed KP | 172 (23.6%) | 44 (22.2%) | 95 (34.3%) | 26 (18.8%) | 7 (6.0%) | < 0.001 |
[02] ALI | 125 (17.1%) | 4 (2.0%) | 33 (11.9%) | 47 (34.1%) | 41 (35.0%) | |
[03] PBK | 82 (11.2%) | 6 (3.0%) | 34 (12.3%) | 26 (18.8%) | 16 (13.7%) | |
[04] Glaucoma surgery | 78 (10.7%) | 14 (7.1%) | 48 (17.3%) | 16 (11.6%) | 0 (0.0%) | |
[05] Corneal opacity | 48 (6.6%) | 40 (20.2%) | 7 (2.5%) | 0 (0.0%) | 1 (0.9%) | |
[06] FED | 48 (6.6%) | 0 (0.0%) | 17 (6.1%) | 3 (2.2%) | 28 (23.9%) | |
[07] XFS | 27 (3.7%) | 1 (0.5%) | 11 (4.0%) | 6 (4.3%) | 9 (7.7%) | |
[08] Keratoconus | 21 (2.9%) | 21 (10.6%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
[09] Perforation | 17 (2.3%) | 17 (8.6%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
[10] Infection | 13 (1.8%) | 13 (6.6%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
[11] CMV | 12 (1.6%) | 0 (0.0%) | 7 (2.5%) | 1 (0.7%) | 4 (3.4%) | |
[12] Corneal dystrophy/degeneration | 11 (1.5%) | 7 (3.5%) | 1 (0.4%) | 0 (0.0%) | 3 (2.6%) | |
[13] ICE | 3 (0.4%) | 1 (0.5%) | 2 (0.7%) | 0 (0.0%) | 0 (0.0%) | |
[14] Others | 73 (10.0%) | 30 (15.2%) | 22 (7.9%) | 13 (9.4%) | 8 (6.8%) | |
Failed KP breakdown, n | ||||||
[1] Failed PK | 67 | 36 | 14 | 15 | 2 | |
[2] Failed DSAEK | 67 | 5 | 58 | 4 | 0 | |
[3] Failed nDSAEK | 17 | 0 | 9 | 6 | 2 | |
[4] Failed DMEK | 15 | 0 | 12 | 0 | 3 | |
[5] Failed DALK | 5 | 3 | 2 | 0 | 0 | |
[6] Unknown | 1 | 0 | 0 | 1 | 0 |
ALI argon laser iridotomy, CMV cytomegalovirus, DALK Deep anterior lamellar keratoplasty, DMEK Descemet membrane endothelial keratoplasty, (n)DSAEK (non-)Descemet’s stripping automated endothelial keratoplasty, FED Fuchs’ endothelial dystrophy, ICE iridocorneal endothelial syndrome, PBK pseudophakic bullous keratopathy, PK penetrating keratoplasty, XFS exfoliation syndrome.
Significant values are given in bold.
1Chi-square test.